# Clinical Study of Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation

> **NCT03255265** · — · UNKNOWN · sponsor: **Fuzhou General Hospital** · enrollment: 950 (estimated)

## Conditions studied

- Organ Transplant Rejection

## Interventions

- **OTHER:** no interventions

## Key facts

- **NCT ID:** NCT03255265
- **Lead sponsor:** Fuzhou General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2021-09-28
- **Final completion:** 2021-12-31
- **Target enrollment:** 950 (ESTIMATED)
- **Last updated:** 2017-08-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03255265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03255265, "Clinical Study of Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03255265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*